Mouse Anti-Human CD61 Antibody (S-R618)

產(chǎn)品型號：S0B5070

更新時間：2025-10-08

廠商性質(zhì)：生產(chǎn)廠家

訪問量：49

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

乳腺病理免疫組化解碼：從標(biāo)記物判讀到陷阱規(guī)避全指南

成纖維細(xì)胞生長因子-1（FGF1）如何重編程疾病命運與國自然研究新范式

大鼠免疫球蛋白的免疫功能及應(yīng)用價值

視黃醇結(jié)合蛋白4（RBP4）抗體：發(fā)掘其在疾病風(fēng)險中的診斷潛力

產(chǎn)品介紹

CD61, also known as integrin β3 or GPIIIa, is a membrane glycoprotein that forms heterodimeric complexes with other integrins, such as CD41 （forming the GPIIb/IIIa complex） and CD51 （forming the αvβ3 integrin）. It is primarily expressed on platelets, megakaryocytes, endothelial cells, osteoclasts, and some tumor cells. The CD61/CD41 complex is crucial for platelet aggregation and blood clotting through interactions with fibrinogen and von Willebrand factor. Additionally, CD61 plays a role in cell adhesion, migration, and invasion in various physiological and pathological processes, including tumor metastasis and viral infections. In clinical settings, CD61 is used as a biomarker for identifying platelets and megakaryocytes, and its upregulation in tumors is associated with poor prognosis in several cancers.

上一個：S0B5071Mouse Anti-Human CD68 Antibody (S-R657)